GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.GATA4 and GATA6 transcription factors cooperate to maintain pancreatic ductal adenocarcinoma (PDAC) classical phenotype. Low expression of both GATA4 and GATA6 correlates with poor patient survival and suggests potential as biomarkers.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- GATA6 is a critical regulator of the classical phenotype in pancreatic ductal adenocarcinoma (PDAC), with low expression linked to poor outcomes.
- GATA4 is the second most abundant GATA factor in the pancreas, suggesting a potential role in PDAC.
Purpose Of The Study
- To investigate the contribution of GATA4 to PDAC phenotype.
- To analyze the association between GATA4 and GATA6 expression levels and patient outcomes and chemotherapy response.
Main Methods
- Analysis of PDAC transcriptomic data to identify differentially expressed genes and pathways based on GATA4 and GATA6 expression.
- Assessment of GATA4 genome-wide distribution and the effects of GATA4 knockdown.
- Multicenter tissue microarray study (n=745) to evaluate GATA4 and GATA6 expression in resectable PDAC samples.
- Statistical analysis using Cox regression models to correlate expression levels with patient survival.
Main Results
- GATA4 mRNA is enriched in classical PDAC tumors.
- Reduced GATA4 expression had a minor transcriptional impact but amplified the effects of low GATA6 expression.
- GATA4 and GATA6 share overlapping genome-wide distribution, primarily at promoters.
- Co-expression of low GATA4 and GATA6 was associated with the worst patient survival.
- GATA4 and GATA6 expression decreased in metastases and correlated negatively with basal markers.
Conclusions
- GATA4 and GATA6 collaborate to sustain the classical PDAC phenotype.
- GATA4 and GATA6 expression levels serve as potential biomarkers for poor prognosis and predicting therapeutic response in PDAC.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...